Exponent CEO exercises options, sells 1,663 shares
Catherine Corrigan, President & CEO of Exponent Inc., exercised 2,380 non-qualified stock options on January 15, 2026 at an exercise price of $29.05 per share, receiving common stock.
Rhea-AI Filing Summary
Catherine Corrigan, President & CEO of Exponent Inc., exercised 2,380 non-qualified stock options on January 15, 2026 at an exercise price of $29.05 per share, receiving common stock. That same day she sold 1,663 shares at $72.5158 per share and now directly holds 92,723 shares of Exponent common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
3 txns
Insider
Corrigan Catherine
Role
President & CEO
Sold
1,663 shs ($121K)
Approx. gross sale proceeds
$121K
Approx. exercise cost
$69K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) | 2,380 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,380 | $29.05 | $69K |
| Sale | Common Stock | 1,663 | $72.5158 | $121K |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 16,658 contracts (Direct);
Common Stock — 92,723 shares (Direct)
Footnotes (2)
- F1. The stock option becomes exercisable in four equal annual installments.
- F2. Not applicable.
Key Figures
Options Exercised: 2,380 shares
Option Exercise Price: $29.0500 per share
Shares Sold: 1,663 shares
+2 more
5 metrics
Options Exercised
2,380 shares
Non-Qualified Stock Options exercised on 2026-01-15
Option Exercise Price
$29.0500 per share
Exercise price of Non-Qualified Stock Options
Shares Sold
1,663 shares
Common stock sale on 2026-01-15
Sale Price
$72.5158 per share
Price per share for common stock sale
Post-transaction Holdings
92,723 shares
Direct Exponent common stock held after transactions
Key Terms
Non-Qualified Stock Option (right to buy), derivative security, open market or private transaction
3 terms
Non-Qualified Stock Option (right to buy) financial
"Reported security as a Non-Qualified Stock Option (right to buy) exercised into common stock"
derivative security financial
"Transaction described as an exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
open market or private transaction financial
"Sale in open market or private transaction for the common stock sale"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Exponent (EXPO) CEO Catherine Corrigan report?
Catherine Corrigan reported an option exercise and a share sale. She exercised 2,380 non-qualified stock options at $29.05 per share and on the same date sold 1,663 shares of Exponent common stock at $72.5158 per share.
How many Exponent (EXPO) stock options did Catherine Corrigan exercise and at what price?
Catherine Corrigan exercised 2,380 non-qualified stock options on January 15, 2026 at an exercise price of $29.05 per share. These options were exercised into Exponent common stock as part of her reported Form 4 transactions.
What type of equity award did Exponent (EXPO) grant that Catherine Corrigan exercised?
The exercised award was a Non-Qualified Stock Option (right to buy). Footnote disclosure states that the stock option becomes exercisable in four equal annual installments, indicating a multi-year vesting structure for this type of grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
